Various compounds that inactivate or inhibit protease and phosphatase activity have been validated. Our company offers protease inhibitors, phosphatase inhibitors, and universal inhibitors for selection. EDTA-free inhibitors are suitable for assays sensitive to divalent cations. Available in powder, concentrated liquid, and tablet formats, they comprehensively and efficiently protect protein integrity during protein extraction.
Cat. No. | Description | Packaging |
BL507A | PMSF (100mM) | 10mL |
BL1426A | PMSF Solution (100mM) | 10mL |
BL612A | Protease Inhibitor, Universal Type, 100× | 1mL |
BL612B | Protease Inhibitor, Universal Type, 100× | 5×1mL |
BL629A | Protease Inhibitor Cocktail (EDTA-Free, Mini Tablet, for 10mL) | 10mL/tablet |
BL629B | Protease Inhibitor Cocktail (EDTA-Free, Mini Tablet, for 10mL) | 10mL/tablet , 10 tablets/box |
BL630A | Protease Inhibitor Cocktail (EDTA-Free, Mini Tablet, for 50mL) | 50mL/tablet |
BL630B | Protease Inhibitor Cocktail (EDTA-Free, Mini Tablet, for 50mL) | 50mL/tablet, 10 tablets/box |
BL615A | Phosphatase Inhibitor, 100× | 2×1mL |
BL636A | Phosphatase Inhibitor Cocktail (Mini Tablet, for 25mL) | 25mL/tablet |
BL636B | Phosphatase Inhibitor Cocktail (Mini Tablet, for 25mL) | 25mL/tablet, 10tablets/box |
BL1439A | Protease and Phosphatase Inhibitor Cocktail (Universal Type, 100×) | 1mL |
BL1187A | Deacetylase Inhibitor (100×) | 1mL |
BL1187B | Deacetylase Inhibitor (100×) | 5×1mL |
Comparison Table of Characteristics and Differences of Various Protease Inhibitors
Various compounds that inactivate or inhibit protease and phosphatase activity have been validated. Our company offers protease inhibitors, phosphatase inhibitors, and universal inhibitors for selection. EDTA-free inhibitors are suitable for assays sensitive to divalent cations. Available in powder, concentrated liquid, and tablet formats, they comprehensively and efficiently protect protein integrity during protein extraction.
Cat. No. | Description | Packaging |
BL507A | PMSF (100mM) | 10mL |
BL1426A | PMSF Solution (100mM) | 10mL |
BL612A | Protease Inhibitor, Universal Type, 100× | 1mL |
BL612B | Protease Inhibitor, Universal Type, 100× | 5×1mL |
BL629A | Protease Inhibitor Cocktail (EDTA-Free, Mini Tablet, for 10mL) | 10mL/tablet |
BL629B | Protease Inhibitor Cocktail (EDTA-Free, Mini Tablet, for 10mL) | 10mL/tablet , 10 tablets/box |
BL630A | Protease Inhibitor Cocktail (EDTA-Free, Mini Tablet, for 50mL) | 50mL/tablet |
BL630B | Protease Inhibitor Cocktail (EDTA-Free, Mini Tablet, for 50mL) | 50mL/tablet, 10 tablets/box |
BL615A | Phosphatase Inhibitor, 100× | 2×1mL |
BL636A | Phosphatase Inhibitor Cocktail (Mini Tablet, for 25mL) | 25mL/tablet |
BL636B | Phosphatase Inhibitor Cocktail (Mini Tablet, for 25mL) | 25mL/tablet, 10tablets/box |
BL1439A | Protease and Phosphatase Inhibitor Cocktail (Universal Type, 100×) | 1mL |
BL1187A | Deacetylase Inhibitor (100×) | 1mL |
BL1187B | Deacetylase Inhibitor (100×) | 5×1mL |
Comparison Table of Characteristics and Differences of Various Protease Inhibitors
